Xencor Inc

1
NAS:XNCR (USA)  
$ 22.79 -3.73 (-14.06%) 10:09 PM EST
At Loss
P/B:
2.07
Volume:
3.43M
Avg Vol (2M):
630.96K
Also Trade In:
Volume:
3.43M
At Loss
Avg Vol (2M):
630.96K

Business Description

Description
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 8.14
Equity-to-Asset 0.86
Debt-to-Equity 0.09
Debt-to-EBITDA -0.45
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.31
Distress
Grey
Safe
Beneish M-Score -1.76
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.53
9-Day RSI 49.6
14-Day RSI 53.1
6-1 Month Momentum % -11.35
12-1 Month Momentum % -37.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.77
Quick Ratio 10.77
Cash Ratio 9.32
Days Sales Outstanding 84.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.8
Shareholder Yield % -1.35

Financials (Next Earnings Date:2024-05-08 Est.)

XNCR's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:XNCR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Xencor Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 145.259
EPS (TTM) ($) -1.99
Beta 0.69
Volatility % 30.29
14-Day RSI 53.1
14-Day ATR ($) 1.378651
20-Day SMA ($) 21.6715
12-1 Month Momentum % -37.5
52-Week Range ($) 16.49 - 32.59
Shares Outstanding (Mil) 60.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Xencor Inc Filings

Filing Date Document Date Form
No Filing Data

Xencor Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Xencor Inc Frequently Asked Questions

What is Xencor Inc(XNCR)'s stock price today?
The current price of XNCR is $22.79. The 52 week high of XNCR is $32.59 and 52 week low is $16.49.
When is next earnings date of Xencor Inc(XNCR)?
The next earnings date of Xencor Inc(XNCR) is 2024-05-08 Est..
Does Xencor Inc(XNCR) pay dividends? If so, how much?
Xencor Inc(XNCR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1